← Open Payments lookup

ALEKSEY ARONOV: Open Payments

NPI 1548616451 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,241 in 48 payments from 14 companies in 2025. Trend: 2023 $2,226 · 2024 $1,242 · 2025 $1,241

Food & beverage: $1,241
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation11$222
Celgene Corporation8$214
Takeda Pharmaceuticals U.S.A., Inc.5$209
GlaxoSmithKline, LLC.5$115
Blueprint Medicines Corporation3$104
Kite Pharma, Inc.5$100
GENZYME CORPORATION3$89
Rigel Pharmaceuticals, Inc.2$57
Merck Sharp & Dohme LLC1$28
Daiichi Sankyo Inc.1$28

Products named: SCEMBLIX, REBLOZYL, AYVAKIT, ICLUSIG, OJJAARA, Yescarta, NINLARO, TAVALISSE.

Industry payments across NY — which companies pay providers there.